Overactive bladder drugs may not raise dementia risk, according to a new study published in JAMA Network Open.
The FDA has approved tildrakizumab for psoriatic arthritis treatment, expanding its use beyond plaque psoriasis.
New research shows large language models may uncover hidden dimensions in chronic pain assessment that traditional severity scales miss, analyzing 131 patient…
Physicians encouraged to adopt failure as a learning tool to improve healthcare excellence.
Boehringer Ingelheim's obesity drug trial results show a 13.1% weight loss, a disappointing outcome in the competitive market dominated by Eli Lilly…